Finance

Beta
Lists
Equity sectors
Symbols
Symbols
Price
Change
% Change
Trend
Prev Close
Open
High
Low
Volume
Mkt Cap
SIXB
Materials
SIXB
Materials
SIXB
-0.21%
1,091.51
-2.30
-0.21%
—1,093.811,096.521,100.221,091.51——
SIXC
Communications
SIXC
Communications
SIXC
+0.22%
610.11
+1.34
+0.22%
—608.77608.77612.97608.77——
SIXE
Energy
SIXE
Energy
SIXE
-1.34%
1,237.98
-16.83
-1.34%
—1,254.811,253.011,253.871,226.33——
SIXI
Industrials
SIXI
Industrials
SIXI
-0.93%
1,744.71
-16.40
-0.93%
—1,761.111,764.271,766.881,744.71——
SIXM
Financials
SIXM
Financials
SIXM
-0.37%
640.18
-2.40
-0.37%
—642.58644.87648.48640.18——
SIXR
Staples
SIXR
Staples
SIXR
-0.18%
849.58
-1.55
-0.18%
—851.13855.66858.75845.56——
SIXRE
Real estate
SIXRE
Real estate
SIXRE
-0.23%
217.48
-0.50
-0.23%
—217.98217.98218.65216.88——
SIXT
Technology
SIXT
Technology
SIXT
+1.52%
3,260.69
+48.86
+1.52%
—3,211.833,227.213,268.383,226.55——
SIXU
Utilities
SIXU
Utilities
SIXU
-0.69%
942.45
-6.53
-0.69%
—948.98948.58957.83941.97——
SIXV
Health care
SIXV
Health care
SIXV
-0.52%
1,466.80
-7.72
-0.52%
—1,474.521,479.031,481.041,466.80——
SIXY
Discretionary
SIXY
Discretionary
SIXY
+0.22%
2,397.50
+5.38
+0.22%
—2,392.122,396.952,421.222,382.32——
49Z:FRA
BICO Group AB
€1.98
+10.24%
(+0.18) 1D
Apr 30, 10:00:00 PM GMT+2  ·   EUR
All symbols
SymbolPriceChange% Change
Generating top insights for 49Z...
Open
€1.89
High
€1.98
Low
€1.89
Mkt. cap
1.49B
Avg. vol.
432.00
Volume
750.00
52-wk high
€3.66
52-wk low
€1.47
No. of employees
570
News stories
From sources across the web
Profile
Bico Group is a Swedish bioconvergence company that designs and supplies technologies and services to enhance biology research. It focuses on commercializing technologies for life science research as well as bioprinting. Bico Group began by producing bio-inks and bioprinters for culturing different cell types to enable applications like patient-derived implants. Bico Group was the first company to provide a standardized bio-ink product for sale over the internet. The company has ongoing collaborations with organizations including AstraZeneca, MedImmune, MIT and Takara Bio, and its bioprinters are used for research at Harvard University, Merck, Novartis, the U.S. Army, Toyota, Johnson & Johnson and more. Wikipedia
About BICO Group AB
CEO-
Employees570
FoundedJan 27, 2016
Headquarters-
SectorHealth care
Websitebico.com
Previous reportsAll values in SEK
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in SEK
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Revenue
324.20M
386.90M
451.30M
329.90M
Cost of goods sold
181.80M
174.20M
215.90M
151.30M
Cost of revenue
181.80M
174.20M
215.90M
151.30M
Research and development expenses
54.00M
50.10M
48.80M
49.30M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
199.90M
204.10M
204.30M
-
Operating expense
247.90M
259.60M
249.50M
269.80M
Total operating expenses
429.70M
433.80M
465.40M
421.10M
Operating income
-105.50M
-46.90M
-14.10M
-
Other non operating income
200.00K
-
-8.40M
9.10M
EBT including unusual items
-180.30M
-1.11B
-57.00M
-127.50M
EBT excluding unusual items
-180.30M
-73.30M
-73.30M
-
Income tax expense
1.30M
-2.20M
2.20M
-
Effective tax rate
-0.72%
0.20%
-3.86%
-2.98%
Other operating expenses
-6.00M
5.40M
-3.60M
-
Net income
-187.20M
-612.70M
-55.00M
-
Net profit margin
-57.74%
-158.36%
-12.19%
-
Earnings per share
-
-
-
-
Interest and investment income
2.20M
2.70M
212.00M
-
Interest expense
-77.20M
-29.10M
-11.90M
-23.20M
Net interest expenses
-75.00M
-26.40M
200.10M
-23.20M
Depreciation and amortization charges
-
-
-
-
EBITDA
-27.20M
1.04B
48.40M
-
Gain or loss from assets sale
-
-
-480.30M
-
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

My tasks
You haven't created a task yet
Your tasks will appear here. Schedule tasks and put Google Finance to work while you're away.
Templates
Watchlist briefing
A daily pre-market analysis of your watchlist
Upcoming Earnings
Upcoming earnings reports in the week
Abnormal Volatility & Volume
Volatility and volume early warning today
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer